Back to XTX Topco Ltd XTX Topco Ltd

CYTKCYTK
13 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in CYTOKINETICS INC

Yes. XTX Topco holds 80,743 shares of CYTK (Cytokinetics), worth $6.9M, as of its Q2 2026 13F filing. It increased the position from 23,853 shares in Q1 2026. XTX Topco has held CYTK since Q3 2025, across 4 quarterly 13F filings. CYTK is 0.1% of XTX Topco's reported 13F portfolio.

Current Value

$6.9M

Current Shares

80,743

Total Value Change

+$6.2M

Total Shares Change

+63,932

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
80,743
+238.5%
$6.9M0.1%$85.19
44
2026-Q1
Decreased
23,853
-73.7%
$1.6M0.0%$65.91
0
2025-Q4
Increased
90,579
+2170.2%
$5.8M0.2%$63.54
52
2025-Q3
New
3,990
-
$219,2900.0%$54.96
32
2025-Q2
Exited
0
-100.0%
$00.0%$33.04
0
2025-Q1
Decreased
7,357
-23.8%
$295,6780.0%$40.19
0
2024-Q4
Decreased
9,650
-2.2%
$453,9360.0%$47.04
0
2024-Q3
New
9,871
-
$521,1890.0%$52.80
33
2024-Q1
Exited
0
-100.0%
$00.0%$70.11
0
2023-Q4
Decreased
4,178
-77.5%
$348,8210.1%$83.49
0
2023-Q3
New
18,596
-
$547,8380.1%$29.46
34
2022-Q3
Exited
0
-100.0%
$00.0%$48.45
0
2022-Q2
New
16,811
-
$661,0000.3%$39.29
41

Other major holders of CYTK: BlackRock, Inc., BlackRock Finance, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used